Agilent, 863600-911, AdvanceBio Peptide Mapping, 1.0 x 150 mm, 2.7 µm

AdvanceBio Peptide Mapping, 1.0 x 150 mm, 2.7 µm. Reversed-phase HPLC column with superficially porous particle support with a C18 column chemistry designed and optimized for the analysis of the peptides produced by enzymatic digest of proteins

Specifications:
Brand: AdvanceBio Peptide Mapping
Hardware: SS
Inner Diameter (ID): 1 mm
LC Platform: Stainless Steel
Length: 150 mm
Maximum Temperature: 60 °C
Part Number Application: Peptide Mapping
Part Number Application Domain: Biopharma
Particle Size: 2.7 µm
Particle Type: Superficially Porous
Phase: C18
Pore Size: 120 Å
Pressure Rating: 600 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115711
pH Range: 2-8

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The AdvanceBio Peptide Mapping column, with dimensions of 1.0 x 150 mm and a 2.7 µm particle size, is designed specifically for high-resolution mapping of peptides in biopharmaceutical research and quality control. Engineered with superficially porous particles, this column delivers outstanding separation efficiency, sharp peak shapes, and reliable reproducibility, meeting the rigorous standards required for peptide mapping workflows. It is ideal for the characterization of monoclonal antibodies, biosimilars, and other protein therapeutics, facilitating applications such as identification of post-translational modifications, sequence confirmation, and impurity profiling.

This column is optimized for use with a range of UHPLC and HPLC systems, including Agilent 1260 Infinity II and 1290 Infinity II platforms, as well as instruments from other major manufacturers. Its robust design supports compatibility with both UV and MS detection, enabling sensitive analysis across diverse sample matrices. AdvanceBio Peptide Mapping columns integrate seamlessly with related Agilent products such as peptide sample preparation kits and LC-MS systems, supporting streamlined peptide analysis workflows. The column’s consistent performance enhances confidence in peptide identification and quantitation, making it a reliable choice for proteomics research, method development, and regulatory compliance in pharmaceutical laboratories.